Home » NOVEN EARNS MILESTONE PAYMENT UNDER P&G COLLABORATION
NOVEN EARNS MILESTONE PAYMENT UNDER P&G COLLABORATION
Noven Pharmaceuticals has earned a $3 million success fee for attaining a development milestone under its development collaboration with P&G Pharmaceuticals, a subsidiary of The Procter & Gamble Company. Noven expects to report the $3 million success fee as license and contract revenues for the quarter ending Dec. 31, 2004.
PharmaBiz (http://www.pharmabiz.com/article/detnews.asp?articleid=25506)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct